Atrial Tachycardia is a cardiac arrhythmia characterized by a rapid heartbeat originating in the atria, the upper chambers of the heart. Unlike normal heartbeats that are regulated by the sinoatrial (SA) node, individuals with atrial tachycardia experience an abnormal firing of electrical signals from within the atria, leading to a faster heart rate than the typical range of 60 to 100 beats per minute. This condition can be episodic or sustained, causing symptoms such as palpitations, shortness of breath, and dizziness. Diagnosis often involves the use of electrocardiograms (ECGs) to detect the rapid heart rhythm. Management strategies may include medications to control the heart rate, radiofrequency ablation to eliminate the abnormal electrical pathways, or, in severe cases, implantation of a pacemaker. A comprehensive understanding of the underlying causes, risk factors, and available treatment options is crucial for healthcare professionals to effectively manage and improve the quality of life for individuals with atrial tachycardia.
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya